Pcv71 - Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Symptomatic Chronic Heart Failure With Reduced Ejection Fraction in Portugal

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.618
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcv82 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction in Singapore

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction: Cost and Effectiveness in the Italian Context

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

The Reverse Remodeling Response to Sacubitril/Valsartan Therapy in Heart Failure With Reduced Ejection Fraction

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2018English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Parasail Study- Canadian Real World Experience Use of Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Pcv105 - Potential Reduction in Mortality and Hospitalisations With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure With Reduced Ejection Fraction in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Outcomes of Chronic Kidney Disease and Heart Failure With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Pcv86 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure Under the Brazilian Private Healthcare System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy